ebselen has been researched along with arenobufagin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YQ; Chen, WM; Hou, W; Huang, ZX; Lin, H; Lin, J; Peng, QL; Sun, PH; Wang, LH; Xu, HG; Yao, Z; Zhang, DM | 1 |
1 other study(ies) available for ebselen and arenobufagin
| Article | Year |
|---|---|
Hybrids of arenobufagin and benzoisoselenazol reducing the cardiotoxicity of arenobufagin.
Topics: Antineoplastic Agents; Bufanolides; Cardiotoxicity; Cell Line, Tumor; Drug Design; Free Radical Scavengers; Humans; Molecular Structure; Myocytes, Cardiac; Organoselenium Compounds; Reactive Oxygen Species | 2018 |